These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22477551)

  • 1. Low levels of soluble receptor for advanced glycation end products in non-ST elevation myocardial infarction patients.
    McNair ED; Wells CR; Qureshi AM; Basran RS; Pearce C; Orvold J; Devilliers J; Prasad K
    Int J Angiol; 2009; 18(4):187-92. PubMed ID: 22477551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble receptors for advanced glycation end products (sRAGE) as a predictor of restenosis following percutaneous coronary intervention.
    McNair ED; Wells CR; Mabood Qureshi A; Basran R; Pearce C; Orvold J; Devilliers J; Prasad K
    Clin Cardiol; 2010 Nov; 33(11):678-85. PubMed ID: 21089112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of high sensitivity C-reactive protein by soluble receptor for advanced glycation end products.
    McNair ED; Wells CR; Mabood Qureshi A; Basran R; Pearce C; Orvold J; Devilliers J; Prasad K
    Mol Cell Biochem; 2010 Aug; 341(1-2):135-8. PubMed ID: 20339904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse Association between Cardiac Troponin-I and Soluble Receptor for Advanced Glycation End Products in Patients with Non-ST-Segment Elevation Myocardial Infarction.
    McNair ED; Wells CR; Qureshi AM; Pearce C; Caspar-Bell G; Prasad K
    Int J Angiol; 2011 Mar; 20(1):49-54. PubMed ID: 22532771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality.
    Prasad K
    Int J Angiol; 2014 Mar; 23(1):11-6. PubMed ID: 24627612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
    Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
    Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases?
    Prasad K
    Mol Cell Biochem; 2019 Jan; 451(1-2):139-144. PubMed ID: 29961210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease.
    Prasad K; Dhar I; Zhou Q; Elmoselhi H; Shoker M; Shoker A
    Mol Cell Biochem; 2016 Dec; 423(1-2):105-114. PubMed ID: 27714575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of Advanced Glycation End Products Involved in Inflammation and Contributing to Severe Preeclampsia, in Maternal Blood, Umbilical Blood and Placental Tissues.
    Chen W; Zhang Y; Yue C; Ye Y; Chen P; Peng W; Wang Y
    Gynecol Obstet Invest; 2017; 82(4):388-397. PubMed ID: 27505171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto's thyroiditis.
    Ruggeri RM; Barbalace MC; Cristani MT; Alibrandi A; Giovinazzo S; Giuffrida G; Trimarchi F; Cannavò S; Campennì A
    J Endocrinol Invest; 2020 Sep; 43(9):1337-1342. PubMed ID: 32232775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerosis and the Hypercholesterolemic AGE-RAGE Axis.
    McNair E; Qureshi M; Prasad K; Pearce C
    Int J Angiol; 2016 Jun; 25(2):110-6. PubMed ID: 27231427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end products (AGEs) and its receptors in the pathogenesis of hyperthyroidism.
    Caspar-Bell G; Dhar I; Prasad K
    Mol Cell Biochem; 2016 Mar; 414(1-2):171-8. PubMed ID: 26895319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging markers of inflammation and oxidative stress as potential predictors of coronary artery disease.
    Tsirebolos G; Tsoporis JN; Drosatos IA; Izhar S; Gkavogiannakis N; Sakadakis E; Triantafyllis AS; Parker TG; Rallidis LS; Rizos I
    Int J Cardiol; 2023 Apr; 376():127-133. PubMed ID: 36758863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients.
    Assiri AMA; Kamel HFM; ALrefai AA
    Med Sci (Basel); 2018 May; 6(2):. PubMed ID: 29789493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Kurita-Nakamura Y; Matsui T; Yoshida T; Imaizumi T
    Mol Med; 2007; 13(3-4):185-9. PubMed ID: 17592553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis.
    Machahua C; Montes-Worboys A; Planas-Cerezales L; Buendia-Flores R; Molina-Molina M; Vicens-Zygmunt V
    Respir Res; 2018 Nov; 19(1):215. PubMed ID: 30409203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
    Moriya S; Yamazaki M; Murakami H; Maruyama K; Uchiyama S
    J Stroke Cerebrovasc Dis; 2014; 23(10):2540-2546. PubMed ID: 25282185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
    Melin EO; Dereke J; Hillman M
    Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension.
    Gryszczyńska B; Budzyń M; Begier-Krasińska B; Osińska A; Boruczkowski M; Kaczmarek M; Bukowska A; Iskra M; Kasprzak MP
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.